One Ship, a Worldwide Crisis: How Can Supply Chains Get Unstuck?

Data drives decisions of the worlds largest companies but in a world with constant data, how do you make sense of it? Host TC Riley, puts the world under the lens of data and analytics and explores current news, B2B trends, and popular topics.

 

The Ever Given will go down in infamy, and not in a good way. Its blockage of the Suez Canal further crippled supply chains already at their breaking points due to the pandemic. How could one incident have such an impact? It’s all clear when diving into the data, and that’s what host TC Riley does in this episode.

“You can’t underestimate the importance of the Suez Canal to global trade. It cuts 3500 nautical miles and around nine days off the trip between Asia and Europe,” Riley said. The number of shipments that pass through it every day is incredible. Over 1,000,000 barrels of oil and 8% of the world’s liquified natural gas go through it daily. During the debacle, the media went in on the economics, most saying it cost the world billions.

The reality may look a little different. “It was a significant shock to global trade, impacting many businesses, but these numbers are drastically blown out of proportion,” Riley explained. It’s more likely that the true economic consequences won’t be known for some time. Riley called it “an excellent example of data not being incorrect but applied inappropriately.”

While this is an extreme example, businesses do this all the time. So, what’s the real impact? What experts can say is that it affected operating costs for shipping companies, primarily in fuel costs. Another area is insurance premiums, as insurance companies were hit hard by the blockage. For the consumer, it may be negligible or show up in temporary oil price increases.

“The biggest takeaway for me is the impact that global supply chains have on so many businesses and how fragile some of those chains are,” Riley remarked. The data won’t be in for some time, and that’s the story with most global emergencies. It’s a good reminder to take in the entire picture that data paints before drawing finite conclusions.

Catch up on all episodes of Diving Into Data!

Follow us on social media for the latest updates in B2B!

Image

Latest

AI in marketing
From Queries to Conversations with AI in Marketing Analytics
April 21, 2025

In this episode of the SparkCast, Aby Varma—founder of Spark Novus, a firm that helps marketing leaders adopt AI responsibly and strategically—sits down with Daniel Kravtsov, CEO and Co-Founder of Improvado. Daniel shares his unique journey from Russia to founding a cutting-edge martech company in the Bay Area. Together, they explore how AI agents…

Read More
ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More